Plesner advised Lundbeck A/S. The global pharmaceutical company H. Lundbeck A/S has just established an EMTN bond programme and a debut issue under the programme. Lundbeck…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
